AI assistant
Sending…
ACADIA PHARMACEUTICALS INC — Director's Dealing 2019
Apr 2, 2019
31237_dirs_2019-04-02_2e24c5b9-df0b-4853-bff0-bdb9c265a840.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2019-03-30
Reporting Person: Ridloff Elena (EVP and CFO)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy) | $15.81 | 2028-04-29 | Common Stock (100000) | Direct |
Footnotes
F1: 25% of the shares subject to the Stock Option vest and become exercisable on April 30, 2019. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
More from ACADIA PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20